首页> 美国卫生研究院文献>Therapeutics and Clinical Risk Management >A case of gait disturbance caused by low-dose gabapentin
【2h】

A case of gait disturbance caused by low-dose gabapentin

机译:小剂量加巴喷丁致步态障碍一例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gabapentin, an anticonvulsant agent, is now often used for the treatment of neuropathic pain all over the world. It is unclear whether the combined use of gabapentin, sodium valproate, and flunitrazepam results in enhancement of the side effect, a gait disturbance. A 60-year-old man was taking oral sodium valproate for symptomatic epilepsy after a brain contusion and flunitrazepam to relieve insomnia. Oral gabapentin therapy was started for suspected neuropathic pain. Although the initial dose of oral gabapentin (200 mg) relieved the pain, the lower extremities became weak, resulting in a gait disturbance. The therapy was restarted with a halved dose, and this resolved the gait disturbance and relieved the pain.
机译:加巴喷丁是一种抗惊厥药,现在在世界范围内经常用于治疗神经性疼痛。尚不清楚加巴喷丁,丙戊酸钠和氟硝西epa的组合使用是否会导致副作用(步态障碍)的增强。一名60岁的男子因脑挫伤和氟尼西epa缓解了失眠,正在服用丙戊酸钠口服以治疗症状性癫痫。对于怀疑的神经性疼痛,开始口服加巴喷丁治疗。尽管口服加巴喷丁的初始剂量(200毫克)可缓解疼痛,但下肢变得虚弱,导致步态障碍。以减半的剂量重新开始治疗,这解决了步态障碍并减轻了疼痛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号